These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 23840054)

  • 1. Measuring cognitive change in subjects with prodromal Alzheimer's disease.
    Mura T; Proust-Lima C; Jacqmin-Gadda H; Akbaraly TN; Touchon J; Dubois B; Berr C
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):363-70. PubMed ID: 23840054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.
    Sarazin M; Berr C; De Rotrou J; Fabrigoule C; Pasquier F; Legrain S; Michel B; Puel M; Volteau M; Touchon J; Verny M; Dubois B
    Neurology; 2007 Nov; 69(19):1859-67. PubMed ID: 17984454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free and cued selective reminding test predicts progression to Alzheimer's disease in people with mild cognitive impairment.
    Grande G; Vanacore N; Vetrano DL; Cova I; Rizzuto D; Mayer F; Maggiore L; Ghiretti R; Cucumo V; Mariani C; Cappa SF; Pomati S
    Neurol Sci; 2018 Nov; 39(11):1867-1875. PubMed ID: 30051200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free and Cued Selective Reminding Test is superior to the Wechsler Memory Scale in discriminating mild cognitive impairment from Alzheimer's disease.
    Lemos R; Cunha C; Marôco J; Afonso A; Simões MR; Santana I
    Geriatr Gerontol Int; 2015 Aug; 15(8):961-8. PubMed ID: 25243721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The free and cued selective reminding test: Validation for mild cognitive impairment and Alzheimer's disease.
    Lemos R; Simões MR; Santiago B; Santana I
    J Neuropsychol; 2015 Sep; 9(2):242-57. PubMed ID: 24894485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial.
    Di Stefano F; Epelbaum S; Coley N; Cantet C; Ousset PJ; Hampel H; Bakardjian H; Lista S; Vellas B; Dubois B; Andrieu S;
    J Alzheimers Dis; 2015; 48(3):793-804. PubMed ID: 26402073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.
    Matias-Guiu JA; Cabrera-Martín MN; Curiel RE; Valles-Salgado M; Rognoni T; Moreno-Ramos T; Carreras JL; Loewenstein DA; Matías-Guiu J
    J Alzheimers Dis; 2018; 61(1):103-111. PubMed ID: 29125488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personality Traits are Related to Selective Cognitive Impairment in Early Alzheimer's Disease.
    Rouch I; Padovan C; Pongan E; Boublay N; Laurent B; Dorey JM; Krolak-Salmon P
    J Alzheimers Dis; 2019; 71(4):1153-1162. PubMed ID: 31524166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The free and cued selective reminding test for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: A prospective longitudinal study.
    Lemos R; Marôco J; Simões MR; Santiago B; Tomás J; Santana I
    J Neuropsychol; 2017 Mar; 11(1):40-55. PubMed ID: 26058529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease.
    Wagner M; Wolf S; Reischies FM; Daerr M; Wolfsgruber S; Jessen F; Popp J; Maier W; Hüll M; Frölich L; Hampel H; Perneczky R; Peters O; Jahn H; Luckhaus C; Gertz HJ; Schröder J; Pantel J; Lewczuk P; Kornhuber J; Wiltfang J
    Neurology; 2012 Feb; 78(6):379-86. PubMed ID: 22238414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of Cognitive Change in Preclinical and Prodromal Alzheimer's Disease Using Change-Point Analysis.
    Williams OA; An Y; Armstrong NM; Kitner-Triolo M; Ferrucci L; Resnick SM
    J Alzheimers Dis; 2020; 75(4):1169-1180. PubMed ID: 32390623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metrological properties of neuropsychological tests for measuring cognitive change in individuals with prodromal Alzheimer's disease.
    Zhang X; Wu Y; He Y; Ge X; Cui J; Han H; Luo Y; Liu L; Wang Z; Yu H;
    Aging Ment Health; 2022 Oct; 26(10):1988-1996. PubMed ID: 34409904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construct validity of the Free and Cued Selective Reminding Test in older adults with memory complaints.
    Clerici F; Ghiretti R; Di Pucchio A; Pomati S; Cucumo V; Marcone A; Vanacore N; Mariani C; Cappa SF
    J Neuropsychol; 2017 Jun; 11(2):238-251. PubMed ID: 26560406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.
    Baker JE; Lim YY; Jaeger J; Ames D; Lautenschlager NT; Robertson J; Pietrzak RH; Snyder PJ; Villemagne VL; Rowe CC; Masters CL; Maruff P
    J Alzheimers Dis; 2018; 65(3):977-988. PubMed ID: 30103330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
    Mistridis P; Krumm S; Monsch AU; Berres M; Taylor KI
    J Alzheimers Dis; 2015; 48(4):1095-107. PubMed ID: 26402083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition Memory Performance as a Cognitive Marker of Prodromal Alzheimer's Disease.
    Goldstein FC; Loring DW; Thomas T; Saleh S; Hajjar I
    J Alzheimers Dis; 2019; 72(2):507-514. PubMed ID: 31594225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "when" matters: Evidence from memory markers in the clinical continuum of Alzheimer's disease.
    Forno G; Parra MA; Thumala D; Villagra R; Cerda M; Zitko P; Ibañez A; Lillo P; Slachevsky A
    Neuropsychology; 2023 Oct; 37(7):753-768. PubMed ID: 37227845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.